Tapentadol is partly metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that increase or repress the exercise/expression of one or more of these enzymes, along with with substrates of those enzymes (because of Competitiveness with the enzyme); some enzyme mediators/substrates demand https://theoy330hmp5.wiki-cms.com/user